Results 11 to 20 of about 1,479,789 (367)

Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma [PDF]

Journal of Cancer Research and Practice, 2015
AbstractMyoepithelial carcinoma (malignant myoepithelioma) (MC) is a rare tumor, defined as a malignant salivary neoplasm composed almost exclusively of tumor cells with myoepithelial differentiation. It can arise in unusual location sites, such as the nasopharynx, and may be difficult to approach.
Ping-Ying Chang, Hsin-Chien Chen, Yi-Jen Peng, Hung-Wen Kao, Ching-Liang Ho, Chieh-Sheng Lu, Chieh-Sheng Lu   +6 more
openaire   +5 more sources

Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma. [PDF]

Journal of Clinical Pathology, 1992
AIMS: To assess the presence of carcinoma in situ (CIS) in patients with nasopharyngeal carcinoma (NPC) and to see if the number of biopsy sites facilitates detection of CIS. METHODS: Formalin fixed, paraffin wax embedded biopsy specimens (n = 285) from 187 patients with NPC in 1987 were studied for the presence of CIS as well as for the histological ...
Chan, CW, Choy, D, Sham, JST, Dickens, P, Nicholls, JM   +4 more
openaire   +4 more sources

The role of the bacterial microbiome in the treatment of cancer

BMC Cancer, 2021
The human microbiome is defined as the microorganisms that reside in or on the human body, such as bacteria, viruses, fungi, and protozoa, and their genomes.
Zi-Kun Yu, Rui-Ling Xie, Rui You, You-Ping Liu, Xu-Yin Chen, Ming-Yuan Chen, Pei-Yu Huang   +6 more
doaj   +1 more source

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Cancer Communications, 2021
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa.
L. Tang, Yupei Chen, Chuanben Chen, Ming-Yuan Chen, N. Chen, Xiaozhong Chen, Xiao-Jing Du, W. Fang, M. Feng, Jin Gao, F. Han, Xia He, Chaosu Hu, Denghua Hu, G. Hu, Hao Jiang, Wei Jiang, F. Jin, J. Lang, Jin-Gao Li, Shaojun Lin, Xu Liu, Qiuhua Liu, Lin Ma, H. Mai, Jiyong Qin, Liangfang Shen, Ying Sun, Pei-guo Wang, Ren-Sheng Wang, Ruo-Zheng Wang, Xiaoshen Wang, Ying Wang, Huifang Wu, Yun-Fei Xia, S. Xiao, Kun-yu Yang, J. Yi, Xiao-dong Zhu, Jun Ma   +39 more
semanticscholar   +1 more source

Accumulated Dose Deviation of Rotational and Residual Setup Errors on Nasopharyngeal Carcinoma Using MIM Treated by Helical Tomotherapy

Technology in Cancer Research & Treatment, 2023
Background To analyze the relationship between the rotational and residual setup errors and the dose deviation on nasopharyngeal carcinoma (NPC) treated by helical tomotherapy (HT).
Wenyan Yao MS, Jiang Hu MS, Peixun Xu BS, Mengxue He MS, Yongwen Fang BS, Mingzhi Liu BS, Zongtai Li BS, Huilang He MS, Hui Liu MS, Wenzhao Sun PhD, Senkui Xu MS   +10 more
doaj   +1 more source

The Evolving Epidemiology of Nasopharyngeal Carcinoma

Cancer Epidemiology, Biomarkers and Prevention, 2021
Background: The epidemiology of nasopharyngeal carcinoma (NPC) has long been a source of fascination due to the malignancy's striking geographic distribution, the involvement of the oncogenic Epstein–Barr virus (EBV), the unique association with intake ...
E. Chang, W. Ye, Y. Zeng, H. Adami
semanticscholar   +1 more source

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.

Journal of Clinical Oncology, 2021
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy for patients with stage II-IVA nasopharyngeal carcinoma (NPC).
Yupei Chen, Nofisat Ismaila, M. Chua, A. Colevas, R. Haddad, Shao Hui Huang, Joseph Wee, Alexander C. Whitley, J. Yi, S. Yom, Anthony T. C. Chan, Chaosu Hu, J. Lang, Q. Le, Anne Lee, N. Lee, Jin-Ching Lin, B. Ma, Thomas J. Morgan, J. Shah, Ying Sun, Jun Ma   +21 more
semanticscholar   +1 more source

Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China

JAMA Oncology, 2022
Key Points Question Is there characteristic microbiota in nasopharyngeal carcinoma (NPC) tissues and, if so, is it associated with prognosis? Findings In this multicenter cohort study including 802 patients with NPC, we confirmed the existence of ...
Han Qiao, Xirong Tan, Hui Li, Junyan Li, Xiaozhong Chen, Yingqin Li, Wen-Fei Li, L. Tang, G. Zhou, Yuan Zhang, Yelin Liang, Qingmei He, Yin Zhao, Shengyan Huang, Sha Gong, Qian Li, Mingxia Ye, Kailin Chen, Ying Sun, Jun Ma, Na Liu   +20 more
semanticscholar   +1 more source

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. [PDF]

, 2014
PurposeWe hypothesized that bortezomib, an agent that suppresses HIF-1α transcriptional activity, when combined with bevacizumab, would obviate the HIF-1α resistance pathway.
Amin, Hesham M, Angelo, Laura S, Falchook, Gerald S, Hess, Kenneth, Hong, David, Howard, Adrienne N, Huang, Mei, Jackson, Edward F, Janku, Filip, Kurzrock, Razelle, Lawhorn, Kristie N, Naing, Aung, Ng, Chaan S, Parkhurst, Kristin L, Tannir, Nizar M, Vishwamitra, Deeksha, Wheler, Jennifer J   +16 more
core   +6 more sources

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma

Cell Death and Differentiation, 2022
Epstein–Barr virus (EBV) was the first oncogenic virus identified in humans. It is primarily associated with multiple lymphoid and epithelial cancers, including nasopharyngeal carcinoma (NPC).
Li Yuan, Shibing Li, Qiu-Yan Chen, Tian-Liang Xia, D. Luo, Liangji Li, Sai-Lan Liu, Shan-Shan Guo, Li-Ting Liu, Chaochao Du, G. Jia, Xiaoyun Li, Zi-Jian Lu, Zhenchong Yang, Huanliang Liu, Haiqiang Mai, Linquan Tang   +16 more
semanticscholar   +1 more source